Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 18, 2026
June 18, 2026
b906dd96-5571-4f8d-81c0-ac787e48c230
Related Documents
Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
Guidance DocumentOctober 20, 2026Center for Drug Evaluation and Research
Submitting Next-Generation Sequencing Data to the Division of Antiviral Products
Guidance DocumentJuly 1, 2026Center for Drug Evaluation and Research
Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals
Guidance DocumentMay 1, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.